S
Sosei Group Corp
TSE:4565
Sosei Group Corp
TSE:4565
Price:
1 414 JPY
-1.81%
Market Closed
Updated:
May 25, 2024
P/E
Price to Earnings
Price to Earnings
-13.9
Current
112.4
Median
22.8
Industry
Lower
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=-13.9
Market Cap
/
126.5B
Net Income
-9.1B
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| JP |
S
|
Sosei Group Corp
TSE:4565
|
126.5B JPY | -13.9 | |
| JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
776 550.9T JPY | -5 347 888.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
767.4B USD | 125 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
4.1T DKK | 46.4 | |
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | -15 783.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
353.7B USD | 9.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
328B USD | 142.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
190.6B GBP | 38.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
183.7B CHF | 16 | |
| CH |
|
Novartis AG
SIX:NOVN
|
179.5B CHF | 11.2 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
163.7B USD | -529.7 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
hidden
2-Years Forward
P/E
hidden
3-Years Forward
P/E
hidden
You don't have any saved screeners yet
